<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta id="journal-meta-263fff5a8c0e457c8c92406a6cb137fd">
      <journal-id journal-id-type="nlm-ta">Sciresol</journal-id>
      <journal-id journal-id-type="publisher-id">Sciresol</journal-id>
      <journal-id journal-id-type="journal_submission_guidelines">https://jmsh.ac.in/</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Sciences and Health</journal-title>
      </journal-title-group>
      <issn publication-format="print"/>
    </journal-meta>
    <article-meta id="article-meta-4120267b9e42409c94aae3ebc6640d84">
      <article-id pub-id-type="doi">10.46347/jmsh.v10.i1.23.220</article-id>
      <article-categories>
        <subj-group>
          <subject>ORIGINAL ARTICLE</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title id="article-title-82e1286a258747f88233aa0edc2b917a">Evaluation <bold id="strong-18a95c6c560e45f4947cd3f6f6f14ee5">o</bold>f Simplified Geboes Score in Ulcerative Colitis</article-title>
        <alt-title alt-title-type="right-running-head">Evaluation of simplified Geboes score in UCs</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name id="n-a26285e524ba">
            <surname>Prasad</surname>
            <given-names>Sruthi</given-names>
          </name>
          <xref id="x-93cf97ab5079" rid="a-ab62ac1b39c5" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="n-16868bf0d760">
            <surname>Krishnamurthy</surname>
            <given-names>Thejasvi</given-names>
          </name>
          <xref id="x-4d4c785e5bde" rid="a-ab62ac1b39c5" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name id="n-891490a5bc48">
            <surname>Priyanka</surname>
            <given-names>M</given-names>
          </name>
          <email>leelavathipriyanka@gmail.com</email>
          <xref id="x-84b049aaa710" rid="a-d207c5f25dfc" ref-type="aff">2</xref>
        </contrib>
        <aff id="a-ab62ac1b39c5">
          <institution>Associate Professor, Department of Pathology, Kempegowda Institute of Medical Sciences</institution>
          <addr-line>Bengaluru</addr-line>
        </aff>
        <aff id="a-d207c5f25dfc">
          <institution>Department of Pathology, Kempegowda Institute of Medical Sciences</institution>
          <addr-line>Bengaluru</addr-line>
        </aff>
      </contrib-group>
      <volume>10</volume>
      <issue>1</issue>
      <fpage>32</fpage>
      <permissions>
        <copyright-year>2024</copyright-year>
      </permissions>
      <abstract id="abstract-abstract-title-83fd11e4ae2140b2bec8d6c688b5c52b">
        <title id="abstract-title-83fd11e4ae2140b2bec8d6c688b5c52b">Abstract</title>
        <p id="paragraph-8118a8fcd6574d9591689f42685cfaa9"><bold id="strong-8c58e2eea452450bbd8b6f5713b3f3d1">Background:</bold> Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology characterized by a relapsing and remitting course. Assessment of disease activity is based on combination of clinical features, endoscopic scoring and histological scoring. Over the years, Histological healing has replaced mucosal healing as the therapeutic endpoint in UC. Various histological parameters have their own significance in predicting treatment outcomes and prognosis. Many histologic scoring systems have been proposed with one such validated score being Geboes score. However, in view of its complexity to use the Simplified Geboes Score (SGS) was developed in 2016. <bold id="strong-98607a91f24e438e82253f8ff028883d">Aim &amp; Objectives:</bold> To assess the interobserver agreement of SGS in ulcerative colitis. <bold id="strong-52fb5ccf57c64f4aaf59360551956904">Methods:</bold> This was retrospective study of 6 years duration. Relevant clinical and endoscopic details were documented. 41 cases of UC were included in the study. The SGS scoring was done by two pathologists independently. Agreement for individual grades of SGS and for the detection of Histologic activity (score &gt;3.1) was compared between both pathologists using Cohen’s kappa coefficient. <bold id="strong-6a0904b875b94954b2bb93e18793e448">Results:</bold> Majority of the patients were in the age group of 15-72 years with male preponderance. Left sided colon was more commonly involved with loose stools being most common symptom. Cohen’s test showed moderate to good agreement for individual grades and good agreement for Histologic activity. <bold id="strong-e9d2065c8dc54cb3881a4115589b0fa6">Conclusion:</bold> The SGS is simple to use and shows good interobserver agreement for histological activity and moderate to good agreement for individual parameter. Therefore, it can be adopted for routine reporting of all biopsies in ulcerative colitis. </p>
      </abstract>
      <kwd-group id="kwd-group-0a1dc4b0f3404ccfbc55b564f440fb1c">
        <title>Keywords</title>
        <kwd>Histological healing</kwd>
        <kwd>Mucosal healing</kwd>
        <kwd>Simplified Geboes Score</kwd>
        <kwd>Ulcerative colitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title id="title-0f17da385a7f4903b729cdf72561d4b5">Introduction</title>
      <p id="paragraph-aa8f1ce592b44f549cfbbf5b9caad5ae">Ulcerative Colitis (UC) is a chronic inflammatory disease of unknown etiology characterized by a relapsing and remitting course <xref id="xref-3f556c179cd94932a51e035956a80b11" rid="R224913830271267" ref-type="bibr">1</xref>. Patients typically present with diarrhea, rectal bleeding and tenesmus <xref id="xref-797a64777f4a443e95993a731c7e26b9" rid="R224913830271272" ref-type="bibr">2</xref>. Chronically uncontrollable disease can lead to development of serious complications like colorectal cancer <xref id="xref-0ac9339dae9c4452bf4919e022b2437e" rid="R224913830271270" ref-type="bibr">3</xref>. Therefore, the determination of disease activity is important for therapeutic monitoring and predicting treatment outcomes <xref id="xref-ecb43dd6637c43a0a24600707b53ad59" rid="R224913830271267" ref-type="bibr">1</xref>. Assessment of disease activity is based on a combination of clinical features, endoscopic scoring and histologic scoring. Clinical and endoscopic remission is no more the therapeutic end point <xref id="xref-f57d66f9c30247d8afe877211b643f8e" rid="R224913830271267" ref-type="bibr">1</xref>. Histologic inflammation is known to persist even with endoscopically normal mucosa, and is known to be associated with increased risk of disease relapse, dysplasia and colorectal cancer <xref id="xref-a530ab05eec54e5b972014fe389e7cc6" rid="R224913830271268" ref-type="bibr">4</xref>. Various histologic scoring systems have been proposed for assessment of disease activity, however only three have undergone extensive validation and these include- Geboes score, Nancy index and Robart’s histopathology index <xref id="xref-026a1d98b3e943fcb1b28dc974d9eaf9" rid="R224913830271268" ref-type="bibr">4</xref>. Though the Geboes score is being used in clinical trials, its application in routine reporting is limited due to its complexity. Hence to overcome this, the Simplified Geboes Score (SGS) was developed in 2016 <xref id="xref-5efeb7609f874d7d9c6a363af7322a1d" rid="R224913830271281" ref-type="bibr">5</xref>.</p>
      <p id="paragraph-02079a266096412a839256ead349d3a0">In view of the presence of multiple parameters, the scoring system may show variability between different pathologists. The aim of this study is to assess the interobserver agreement of SGS in Ulcerative Colitis. </p>
    </sec>
    <sec>
      <title id="title-50da8d343de64d808d870d2a8bb4b8e8">Methodology</title>
      <p id="paragraph-8341835efcd44461b7149460bb0deee3">This was a retrospective study conducted over 6 years from 2013 to 2019. Slides of all endoscopically and histopathologically confirmed cases of ulcerative colitis were retrieved.﻿ Relevant clinical history and endoscopic details were collected from the Department of Gastroenterology and documented. The slides were examined individually by two pathologists (pathologist 1 and pathologist 2). Both pathologists have over 15 years experience in reporting histopathology, with<bold id="strong-8f806ba649c2482c9e649c23c4345e0b"> </bold>one of them being a certified gastrointestinal pathologist. A consensus was reached on the specific diagnostic criteria for grading of individual parameters. Interpretation of the biopsies was done following that. The biopsies were screened and in case of multiple bits, the bits showing maximum activity were selected for interpretation. The Simplified Geboes Scoring system was applied. It includes 6 parameters- No inflammation, Basal plasma cells, Eosinophils in lamina propria, Neutrophils in lamina propria, Neutrophils in epithelium and Epithelial injury (<xref id="x-b60243d6d237" rid="table-wrap-04f85346923c427ba6bc69b062932368" ref-type="table">Table 1</xref>) <xref id="xref-38fc77e300fd44ab87dba4d70c7d1145" rid="R224913830271281" ref-type="bibr">5</xref>.</p>
      <table-wrap id="table-wrap-04f85346923c427ba6bc69b062932368" orientation="portrait">
        <label>Table 1</label>
        <caption id="caption-ebfa26f8e77e4e1584f4114bce42941b">
          <title id="title-f73b8609400f453285386c8c79bb1126">
            <bold id="strong-eec9f9bf4de14632a89061f6ac3c537f">Simplified Geboes Score</bold>
          </title>
        </caption>
        <table id="table-1dbeb177dd1247ef8fcbf393b49569f9" rules="rows">
          <colgroup>
            <col width="16.46"/>
            <col width="8.66"/>
            <col width="21.10000000000001"/>
            <col width="53.78"/>
          </colgroup>
          <tbody id="table-section-7aee4e98fdc04717b76c35801dbb4d18">
            <tr id="table-row-f95e3d6a4cae4ff9be39beab35be3e90">
              <td id="table-cell-6056d986a2cc4250964dbfa0253977d3" align="left">
                <p id="paragraph-a13f46dc0bf5495b87689c8ee2ebfc4b"> <bold id="strong-698f6e1514b04acf870a46061561423b">Grade</bold></p>
              </td>
              <td id="table-cell-6506aebebe684f3ea124839e4b8c4153" colspan="2" align="left">
                <p id="paragraph-c75008d3fc2d4d19952ba207bfa39682"> <bold id="strong-8ae57756bb684028b173e3162a6c24a6">Subgrade</bold></p>
              </td>
              <td id="table-cell-8b210ed4f9a144d4b02b3fb864676342" align="left">
                <p id="paragraph-b7ea1d6e9f454e1d817a98c992b367ab"> <bold id="strong-8ad7b21ce9144c96b3623e0cabb4e0a1">Interpretation</bold></p>
              </td>
            </tr>
            <tr id="table-row-4014f66b9af9406296248e3bb73e9011">
              <td id="table-cell-133533d1bdb547e5b0c3f045d175af2d" rowspan="3" align="left">
                <p id="paragraph-e87ac3b72ca04644980081077bbdcd40"><bold id="strong-ddf09c9a68824b0c89ce37273e05c5a4">Grade 0</bold> <bold id="strong-af0c2b447ce34839899cf7385001899b">No inflammatory activity</bold></p>
              </td>
              <td id="table-cell-23bad25786fb439988a56ffdc1338e9e" align="left">
                <p id="paragraph-0d1c52018bca46e98faf2ea3c75cf59a">0.0 </p>
              </td>
              <td id="table-cell-4cb915b6522048a58937d460a08e24cb" align="left">
                <p id="paragraph-df2c10e14ec84941bde50e486a87bff4">No abnormalities</p>
              </td>
              <td id="table-cell-8fd1d61bff134b8dac06dbf34730615c" align="left">
                <p id="paragraph-7bd26fe166524d599ec3098004b84427"> No active inflammation (neutrophils) or no architectural changes </p>
              </td>
            </tr>
            <tr id="table-row-0c66a91d839b4d16a9bb2777c87c41a2">
              <td id="table-cell-480427ac900f4b81b55e57e92dc877de" align="left">
                <p id="paragraph-74125b96d2fb4b93978ccc5a0b6e0eb8">0.1 </p>
              </td>
              <td id="table-cell-0198ea1035be4fa58b3eb64ee2704c56" align="left">
                <p id="paragraph-265218f930b347bea6e954a11b13c80c">Presence of architectural changes</p>
              </td>
              <td id="table-cell-ba3017a5ac094f1dbd9af07c24e6d11d" align="left">
                <p id="paragraph-5090a44ccb234c5085741b16ed041a31"> Branching crypts, crypts atrophy and loss</p>
              </td>
            </tr>
            <tr id="table-row-060a816f62944a0eb94b1cf15a4a3112">
              <td id="table-cell-6830fe5460334266ba208c4742cf71b8" align="left">
                <p id="paragraph-8ff52e11f919496ebcc589386537f478">0.2</p>
              </td>
              <td id="table-cell-f05652cb14cc4955ae7e164465067d56" align="left">
                <p id="paragraph-63022fe84f104a7bb533b52de189061c">Presence of architectural changes and chronic mononuclear cell infiltrate</p>
              </td>
              <td id="table-cell-807d13102ac04b0ca1abee71f1d73786" align="left">
                <p id="paragraph-00920319213c4fa080d3d27324ec9c96"> Branching crypts, crypts atrophy and loss, lymphoplasmacytic infiltrate.</p>
              </td>
            </tr>
            <tr id="table-row-00564dc822f44ff4aaa51bbe6ed3693d">
              <td id="table-cell-815ab6c451914484a588ed85903ba53c" rowspan="3" align="left">
                <p id="paragraph-afbc404907c14034b0bc70995dca7d6f"><bold id="strong-a1e2e094ab0646fc93299d6de38da9b2">Grade 1</bold> <bold id="strong-02a156562acd4d0881d908f6a5d86f0f">Basal plasma cells</bold></p>
              </td>
              <td id="table-cell-e9e96017ce5a4cec81e1a51925a21563" align="left">
                <p id="paragraph-553466eb010e4758b423f1c0f9282f3d">1.0 </p>
              </td>
              <td id="table-cell-fec5486502a94ceb9a7d40b01c50edfd" align="left">
                <p id="paragraph-9b98c35d951a4027b838e4c3d9b1565e">No increase</p>
              </td>
              <td id="table-cell-825dd416d41848e99e804a211da57631" align="left">
                <p id="paragraph-7899d2b8e4c0478db44d08f4fa9546c5"> No plasma cells</p>
              </td>
            </tr>
            <tr id="table-row-73a2676b8add4db08d2efbad95020cb2">
              <td id="table-cell-92fc389feec642ed965aaba259822213" align="left">
                <p id="paragraph-e4bbc42cfc5543e3af7ad9b844f6bfdb">1.1 </p>
              </td>
              <td id="table-cell-04215c5045384e1c98562c98412e66c9" align="left">
                <p id="paragraph-fa979e5e010b4c16a18c0ed93b9590f4">Mild increase</p>
              </td>
              <td id="table-cell-a424726af57648349ec453e7dbb28561" align="left">
                <p id="paragraph-1a033078449e43d6b5570afd62b3e32e"> Plasma cells seen in single position in single fragments</p>
              </td>
            </tr>
            <tr id="table-row-d53afdf0a1e5437c992fc00e3c893522">
              <td id="table-cell-50675fa6f1cd4cf6a99c6484a940adf3" align="left">
                <p id="paragraph-3aebc41180154ca281b4861ab3dd7419">1.2 </p>
              </td>
              <td id="table-cell-62ed0070fea2418a99ad3b1740d87932" align="left">
                <p id="paragraph-ffc225fc609345dfaa9ce79bd6962c8a">Marked increase</p>
              </td>
              <td id="table-cell-a80131940e0f4383a5ef470e0a30fab0" align="left">
                <p id="paragraph-86552305da0e4953a6cbc22c57ec1a9c"> Multiple fragments in single or multiple slides or band like infiltrate seen in all slides </p>
              </td>
            </tr>
            <tr id="table-row-2fea3422372742d9b7cc52daed65cc23">
              <td id="table-cell-85056cd088da4c47870c7af82ef0bc56" rowspan="3" align="left">
                <p id="paragraph-71d203642a6243d09a5a6dcc8125309b"><bold id="strong-e8b6842272d0447693f02f23c67740dd">Grade 2A</bold> <bold id="strong-dbeeef78513a4372992c5b4b7caa6298">Eosinophils in lamina propria</bold></p>
              </td>
              <td id="table-cell-410b795ac7dd4bea87e0f550bbe2e5ea" align="left">
                <p id="paragraph-b8ea769b600c49c2b0fb1074989787ee">2A.0 </p>
              </td>
              <td id="table-cell-2defda3436194ac7b838c4a5bbde18ad" align="left">
                <p id="paragraph-86335e72c4194352ab4a2979b6b1241d">No increase</p>
              </td>
              <td id="table-cell-b67cfb4ce8904395a12a8d210100da3a" align="left">
                <p id="paragraph-93e4bd318c92475caa638e9986c32507"> Normally few eosinophils are seen in lamina propria</p>
              </td>
            </tr>
            <tr id="table-row-ac4fe93ef911443b8e15df6a7c03bc38">
              <td id="table-cell-b43bd01475f24618976153a55d44f0ca" align="left">
                <p id="paragraph-740db11445a14c1cab71a1b6f329c69b">2A.1 </p>
              </td>
              <td id="table-cell-452fec98554e466ea88ce58063570de7" align="left">
                <p id="paragraph-35b0d5673e4d416588c8a56367f7e1c9">Mild increase</p>
              </td>
              <td id="table-cell-980b8fba2e5240dd879e80c7244d66b0" align="left">
                <p id="paragraph-d49b65618f464266af1d4122ac37764f"> Compact group of eosinophils in lamina propria</p>
              </td>
            </tr>
            <tr id="table-row-9e1755ff70a042dfb3c8223b60ec358c">
              <td id="table-cell-57f9179608de451697ac512c99162dc5" align="left">
                <p id="paragraph-17c9724f4c3c46c3a04494445f074669">2A.2 </p>
              </td>
              <td id="table-cell-786d9ea51c69497b8e9ac17e22fce954" align="left">
                <p id="paragraph-f4cac4a55f42496f81ee0dce8d544bfc">Marked increase</p>
              </td>
              <td id="table-cell-27e77186d6d74cd0bc65d41d63805641" align="left">
                <p id="paragraph-c46ff1a315034bec8a8851c8ce05ab05"> Multiple compact groups or diffuse presence of eosinophils</p>
              </td>
            </tr>
            <tr id="table-row-e2a5ab8f8bd74d4f97172c1b47818b7d">
              <td id="table-cell-33cca0860e0149699a1810e1c46b27d0" rowspan="3" align="left">
                <p id="paragraph-002cc82b2d3c4169828d7a76b4b7b48b"><bold id="strong-f70b334eecb7484abb1d2127b1c17b28">Grade 2B</bold> <bold id="strong-e7eed8961c104083b61ce0b366deeec9">Neutrophils in lamina propria</bold></p>
              </td>
              <td id="table-cell-0c5ef7ce75b64416a6b66e931da84d27" align="left">
                <p id="paragraph-6180d8eeae324009b2ebe9b84f22de3a">2B.0 </p>
              </td>
              <td id="table-cell-5104fda60bc54d7087edf4c8aac78354" align="left">
                <p id="paragraph-946bdfab7ca7465291c1ec9ccee27dd2">No increase</p>
              </td>
              <td id="table-cell-b8620f81d60e47cfb124d7a57cbeea81" align="left">
                <p id="paragraph-b39f4f4aea644c4db54b11c1f48d5bcc"> No neutrophils</p>
              </td>
            </tr>
            <tr id="table-row-d3b6e3a693314089b601f9f073a0b111">
              <td id="table-cell-5557b2a9b0c34390b19cb9606241a99d" align="left">
                <p id="paragraph-747a2be16a634b349c0c33b34ce6d419">2B.1 </p>
              </td>
              <td id="table-cell-0e2e033abfe64802b8f33d1411978ed8" align="left">
                <p id="paragraph-0318e3c3dd5f45ea91982dafc41a88a9">Mild increase</p>
              </td>
              <td id="table-cell-5d940b8c093445dcbbb02e0f409b2709" align="left">
                <p id="paragraph-08b79e6703b24db8b79a109d967a7583"> Neutrophil seen only in 40x</p>
              </td>
            </tr>
            <tr id="table-row-eaf3bce5f24d46c6a49bdab42c1eb6a9">
              <td id="table-cell-783db0d32bb244dcb9e41e1c14853690" align="left">
                <p id="paragraph-0d8d59ef4e624d4dba135802c47a5c48">2B.2 </p>
              </td>
              <td id="table-cell-9bd314d16b4f4a3db7315d5a922971ef" align="left">
                <p id="paragraph-fbd3e25950d147929be274d2f510064d">Moderate increase</p>
              </td>
              <td id="table-cell-18726e04868b403b8239ad430386f6b3" align="left">
                <p id="paragraph-a8faf9c6ec0f449ab16fa37b321bb89c"> Neutrophils seen in low power </p>
              </td>
            </tr>
            <tr id="table-row-2f5802b77ab247c08701b8e04d0f006b">
              <td id="table-cell-2a9333ca7d6342e98d52c266b44090f4" rowspan="3" align="left">
                <p id="paragraph-b1b66a9c5cfb410e9948086de24f6008"><bold id="strong-583f8b6385534eb8aa92a533e15bd123">Grade 3</bold> <bold id="strong-b4ef033fbb28461988a4999b5032419e">Neutrophils in epithelium</bold></p>
              </td>
              <td id="table-cell-c76d1f973a5048ffa26979c318ce01e8" align="left">
                <p id="paragraph-7def8259611e4ffa8d94c0522f4f3c3f">3.0 </p>
              </td>
              <td id="table-cell-bd4c5af5da224fec9c53e34d00d8014f" align="left">
                <p id="paragraph-26cd45eb539141828f436bda8fbbf8c8">None</p>
              </td>
              <td id="table-cell-22dac9681bb740db93ccd8ad11f5a983" align="left">
                <p id="paragraph-f2885c7e863b4528b6d7bca026ba2c64"> No neutrophils in epithelium</p>
              </td>
            </tr>
            <tr id="table-row-3b3ec692efb24e2fbcef0657d8392854">
              <td id="table-cell-2d3309ed2e4d47d6a4f1b6f33e14b5dc" align="left">
                <p id="paragraph-f71bf0cd8ae944b7ae9f30ad8920ec1a">3.1 </p>
              </td>
              <td id="table-cell-7d91e2b8cb324abea7ca4c41cafd6034" align="left">
                <p id="paragraph-5b325854ff6a49ca827fd0b3bf82f159">&lt;50% crypts involved</p>
              </td>
              <td id="table-cell-d7a71995e0814211a2fbd3d0937aa3dd" align="left">
                <p id="paragraph-3bf7ea7dce1f4a149556e25cfd76a051"> Cryptitis, crypt distortion and crypt abscess seen in few crypts</p>
              </td>
            </tr>
            <tr id="table-row-5fb97ed0098b4483a342a74b6ca45fcd">
              <td id="table-cell-a65c30358c584d82b4d1b836d21927d7" align="left">
                <p id="paragraph-ae4cac6b2752489a9da47a45722a2d4d">3.2 </p>
              </td>
              <td id="table-cell-0fef2bb4c3204279bc9f011a2fe5762b" align="left">
                <p id="paragraph-05177b59213e4d7ca93845ca84058981"> &gt;50% crypts involved</p>
              </td>
              <td id="table-cell-b9248c7a382c4c2a9a406bf93be9a946" align="left">
                <p id="paragraph-91055bba6a0147f6a854b79cad9f5026"> Cryptitis, crypt distortion and crypt abscess seen in more crypts</p>
              </td>
            </tr>
            <tr id="table-row-ad56e211442e49659dc5d5368a8a566b">
              <td id="table-cell-750ca3b46dd249c69b301c1a81128f7b" rowspan="5" align="left">
                <p id="paragraph-3125f0bddbc5453c9283d72b0e936648"> <bold id="strong-b4eb418288ba453f98eb49ac297275b8">Grade 4</bold> <bold id="strong-83b89039959c46ff97436a90e2dbd699">Epithelial injury (in crypt and surface epithelium)</bold></p>
              </td>
              <td id="table-cell-1719b22d851745189e1d695ccfbcba33" align="left">
                <p id="paragraph-a5461a6cf3ae4e5aa752e9ffbbfc1b45">4.0 </p>
              </td>
              <td id="table-cell-b21e7a9e43d247a3bd1619696f6b6270" align="left">
                <p id="paragraph-fa75fb0ed8354aa28141555714417edd">None</p>
              </td>
              <td id="table-cell-592b07d18b214ee7920368ba7a687cae" align="left">
                <p id="paragraph-715cb0bbcedc496cb4b614e631fd637b"> -</p>
              </td>
            </tr>
            <tr id="table-row-c758dc77696c462aa1b1ed5f3bf5ca09">
              <td id="table-cell-b8eb29b9ff9d4e0c8f3d49ed4b32d499" align="left">
                <p id="paragraph-dccc408278a64af7ba0ea82b2991f27b">4.1 </p>
              </td>
              <td id="table-cell-251267e3baa9435cb51af60f531dc3ce" align="left">
                <p id="paragraph-1db6a82ec9194c87a877849b802e869d">Marked attenuation</p>
              </td>
              <td id="table-cell-1a96185993d34996b6bab8cf592c5e50" align="left">
                <p id="paragraph-4ac870ba33e141d5865a437c470409c2"> -</p>
              </td>
            </tr>
            <tr id="table-row-c702bff1c6884749816e9c25c3556669">
              <td id="table-cell-f45fe2a6ace54896b6dac52fd67ba253" align="left">
                <p id="paragraph-b251c35a29a7472192984c7206c57266">4.2 </p>
              </td>
              <td id="table-cell-e73d74dd27e34be5ac65d72a225583a5" align="left">
                <p id="paragraph-c856e01f389c41dcac5998c00f5a13d8">Probable crypt destruction: probable erosions</p>
              </td>
              <td id="table-cell-576f9897db084e1aaa3f045bf27e3864" align="left">
                <p id="paragraph-6f77db9318cb40ed94d7f221274ea3b0"> Includes crypt branching, tortuosity, dilation and variation in size and shape</p>
              </td>
            </tr>
            <tr id="table-row-06e3e2fa8d6b44538e9e439453721b6f">
              <td id="table-cell-241089eee5cc4125b863a9b8a1327e1a" align="left">
                <p id="paragraph-cd11c6b03d9241eabfc1f3df82a70f71">4.3 </p>
              </td>
              <td id="table-cell-6e366aa52bea4b5cae75f3bf4ff36e92" align="left">
                <p id="paragraph-81a0844aeb61489a8e6a2064567d5ba3">Unequivocal crypt destruction: unequivocal erosion</p>
              </td>
              <td id="table-cell-9771256c833a4e2f93b9c58aff757eff" align="left">
                <p id="paragraph-f6f2c4cd2db040a0b69ef7e851996b9b"> Loss of continuity between the epithelial cells within the crypts</p>
              </td>
            </tr>
            <tr id="table-row-bfb88d537c6444689b803aa955e40556">
              <td id="table-cell-71adb9778a0945618fa4aacce06693c6" align="left">
                <p id="paragraph-c3a753c5e5d7482ba672755ad37e8464">4.4 </p>
              </td>
              <td id="table-cell-a76163bbfa1f4e7485a6f30405152f41" align="left">
                <p id="paragraph-8f3163496d2f43d1afa43dc9317c9c01">Ulcer or granulation tissue</p>
              </td>
              <td id="table-cell-f006331c24c1493e9f6b565d6c5c7aad" align="left">
                <p id="paragraph-3bc6c9bdb1be4867bf1df9c30efbba81"> Indicates higher grade of inflammation</p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p id="paragraph-0e423a1598b04b278e998aafdac36ea3">All cases of UC were interpreted using SGS, as shown in <xref id="x-17ebcefa1767" rid="table-wrap-04f85346923c427ba6bc69b062932368" ref-type="table">Table 1</xref>  <xref id="xref-ae5f506af46642e1854d18de4c591e0c" rid="R224913830271281" ref-type="bibr">5</xref>. Basic interpretation of few of the parameters was carried out as per the criteria discussed below. Basal plasmacytosis is defined as plasma cells separating the base of colonic crypts from the muscularis mucosae <xref id="xref-3575c6e1a87649e2a0d74ecdee70bea9" rid="R224913830271276" ref-type="bibr">6</xref>. Interpretation of Eosinophils is tricky, as they are normally seen more in the right side of colon than left colon <xref id="xref-f9a7a0aa39344b1d9faa33296130775c" rid="R224913830271271" ref-type="bibr">7</xref>. This was considered while interpreting the biopsies. Neutrophils are not seen in normal colon and presence of any neutrophils either in the lamina propria or epithelium was considered abnormal <xref id="xref-d71a0d98e0eb45b2b069c39f81e7045f" rid="R224913830271275" ref-type="bibr">8</xref>.</p>
      <p id="paragraph-b44493ab0c1743f691ea39b854dc52d3">Histologic activity was defined by a score of ≥3.1 <xref id="xref-73bd15f2121d443987ae1c523d4040fd" rid="R224913830271281" ref-type="bibr">5</xref>. Individual parameters were then analyzed to assess inter observer agreement for each grade and also for histologic activity. The Cohen's kappa test was applied to measure the strength of agreement. The score ranges from 0 to 1, where score of &lt;0.20 indicates very low agreement, 0.20-0.40 is low agreement, 0.41- 0.60 is moderate, 0.61-0.80 is good, 0.81-1.00 is almost perfect and 1 is perfect agreement <xref id="xref-a690710072c44c8392a46244d9126725" rid="R224913830271281" ref-type="bibr">5</xref>.</p>
    </sec>
    <sec>
      <title id="title-6cff9f58ce0b4232b614231a31ab562c">Results</title>
      <p id="paragraph-aed898f35f0241adba82b57cb6c1c131">A total of 42 slides were retrieved. One case was excluded from the study as it showed only granulation tissue and inflammatory exudate. The study included biopsies from 27(65. 8%) male patients and 14(34.1%) female patients. The age of the patients ranged from 15 to 72 years with mean age group of 43years. Most of the patients presented with loose stools. Of the 41 cases, 19 were from the right side of colon and 22 from left side of colon.</p>
      <p id="paragraph-e8cde55aaa4b4d93989369478ec25bf3"><xref id="x-e244ff907083" rid="table-wrap-a2decfddb58e44bc817658d58b7726ca" ref-type="table">Table 2</xref>  shows the frequency distribution of parameters in Simplified Geboes Score by both the pathologists and interobserver agreement measured by kappa coefficient (<xref id="x-dc135322ce7d" rid="table-wrap-a2decfddb58e44bc817658d58b7726ca" ref-type="table">Table 2</xref>  <xref rid="figure-7106e75d8ec8437ca0ed25aa3e7b9455" ref-type="fig">Figure 1</xref>, <xref rid="figure-4dca2914f676454abc321cafd965b673" ref-type="fig">Figure 2</xref>, <xref rid="f-77d6f9f01588" ref-type="fig">Figure 3</xref>, <xref rid="f-a423ed9fc60d" ref-type="fig">Figure 4</xref> ).</p>
      <table-wrap id="table-wrap-a2decfddb58e44bc817658d58b7726ca" orientation="portrait">
        <label>Table 2</label>
        <caption id="caption-450aa846620b4c209bab452182163e98">
          <title id="title-3bf80ddf9261403a88be14ff76e8ee38">
            <bold id="strong-0de93b81fb1f466aa2c35aca2b9a2602">Frequency distribution of SGS parameters and </bold>
            <bold id="strong-31cde014be074caa9f4026d3b337bd71">Interob server agreement</bold>
          </title>
        </caption>
        <table id="table-053924c52a3c43a391015b5ef694b81b" rules="rows">
          <colgroup>
            <col width="12.389999999999999"/>
            <col width="22.93"/>
            <col width="22.53"/>
            <col width="19.619999999999997"/>
            <col width="22.53"/>
          </colgroup>
          <tbody id="table-section-e52c7efde35f4498b29029af9693bc19">
            <tr id="table-row-f59b293e15394ce28948ae81888e832a">
              <td id="table-cell-6ca752d1daaa4e7fb69f16ee2deddc26" align="left">
                <p id="paragraph-639202143397401ea4193e34edd34351">
                  <bold id="strong-081a4a8ca596489d9162a763823e9bbe">Grade</bold>
                </p>
              </td>
              <td id="table-cell-05c1eb0d30d7470fb8bf431dd4972c28" align="left">
                <p id="paragraph-8334b59adb2c4469a2cb0c388fcac754"> <bold id="strong-ba5626d282454f04882c1cad3132ba15">Pathologist 1 (n/ %)</bold></p>
              </td>
              <td id="table-cell-6a5badf3b6de4caea690ec29b93fd91c" align="left">
                <p id="paragraph-8fddbe0b38494bfdb86d54399be28385"> <bold id="strong-9f663c0ff6df44aa972d14fafee7dc9b">Pathologist 2</bold> <bold id="strong-8c9c0f37bb85400fab53fd081a3b4bda">(n/ %)</bold></p>
              </td>
              <td id="table-cell-4479eedf597d4fb990997aa85066aee4" align="left">
                <p id="paragraph-ef65a0f751cc458c8e70cac95499abb3"> <bold id="strong-fc5fdf9436aa4ed492ddbd5319085142">Kappa coefficient</bold></p>
              </td>
              <td id="table-cell-69f8a21d71694a1191a960a4c07ce177" align="left">
                <p id="paragraph-f6b39d6b4b844ad79d9cae657e113ea9"> <bold id="strong-4b443eb43aa24f8481887bae0542a59c">Agreement</bold></p>
              </td>
            </tr>
            <tr id="table-row-b50e7b5cdbb24429996064bd9ff2b7b4">
              <td id="table-cell-29d353568bf142a2bcc41244e7f5d711" colspan="5" align="left">
                <p id="paragraph-645e54d341a347fc80ee81ab7381b40e"> <bold id="strong-4d828fd088ab4b4a8de3b90d2e05abff">Grade 0: </bold>No inflammatory cells</p>
              </td>
            </tr>
            <tr id="table-row-b66416d27be34ef1ad9b577500fa153d">
              <td id="table-cell-0c53a7eedda14ab98c94a6caaea2d872" align="left">
                <p id="paragraph-8f488a5ffa234ba2bfff77fa1852fccb"> 0.0</p>
              </td>
              <td id="table-cell-b80597e3db4e4b29a5ab697713f8aecd" align="left">
                <p id="paragraph-ace6b749fd194d669712a5fdee87a393"> 2 (4.87%)</p>
              </td>
              <td id="table-cell-f91e62bed7c94c378c50954ab941c908" align="left">
                <p id="paragraph-10b18461467b498b9ffa1c6333c942be"> 2 (4.87%)</p>
              </td>
              <td id="table-cell-a6c5769e478c4ffe8349fbfef6904857" rowspan="3" align="left">
                <p id="paragraph-22fd7e43e6b24075b9f91d7b1d9235f2"> 0.513</p>
              </td>
              <td id="table-cell-2b40acc792a04c0e946fe96fa4b55c42" rowspan="3" align="left">
                <p id="paragraph-67f3bdb6bfa34c13866dbbb844995231"> Moderate agreement</p>
              </td>
            </tr>
            <tr id="table-row-16d1414059994f70a0d801463daa06a5">
              <td id="table-cell-f6649ea45b2f4d4db78731ac999ec196" align="left">
                <p id="paragraph-f005fea3af204f199a85f5f89176b6a0"> 0.1</p>
              </td>
              <td id="table-cell-1534b582f6c34a0e8a3697e2f41bbcf3" align="left">
                <p id="paragraph-d62d50212a1e4fa39cfc08b6c15e581a"> 1 (2.43%)</p>
              </td>
              <td id="table-cell-fdfe51515eaa45f09748404311a71d0a" align="left">
                <p id="paragraph-97aa564dc60940f5aae5a3f92cbfec5e"> 2 (4.87%)</p>
              </td>
            </tr>
            <tr id="table-row-ea03b182564947e9932777bd6ab68bec">
              <td id="table-cell-059edb75f02f48e0b7e4aea4091a6427" align="left">
                <p id="paragraph-42093b2e3a3b4cbdbfc45dea332415c6"> 0.2</p>
              </td>
              <td id="table-cell-4e2efb3c29254a0582e9b7bffc12b530" align="left">
                <p id="paragraph-4b32b19f35244d1cbe8d4322c8dd7804"> 38 (92.68%)</p>
              </td>
              <td id="table-cell-22c598f6f6de4bc6a7cd749372d0ac3e" align="left">
                <p id="paragraph-2a9b138e133a476c928abe0c9011e1ca"> 37 (90.24%)</p>
              </td>
            </tr>
            <tr id="table-row-fb59207ec5eb4d7aad9cf7ec540ce445">
              <td id="table-cell-35a8d2b5717f44229ee8184ca2eeb03b" colspan="5" align="left">
                <p id="paragraph-cc6393397b044c86bf1314c66f609f96"> <bold id="strong-c3aa172e060d40f9ab7ff0263d8e27eb">Grade 1: </bold>Basal plasma cells</p>
              </td>
            </tr>
            <tr id="table-row-3132984dc3104b66b460b34a86ed250d">
              <td id="table-cell-208d1cdd136b44478607a5ea938780fc" align="left">
                <p id="paragraph-fe6f145f0b7f4e8a80eeaa592d13aeeb"> 1.0</p>
              </td>
              <td id="table-cell-cdbf5c9c568f4914bb4f84c55b270898" align="left">
                <p id="paragraph-7a48584938d945aa9fa94717cc083006"> 9 (21.95%)</p>
              </td>
              <td id="table-cell-f07990053ee245c0ac134e0d74536f71" align="left">
                <p id="paragraph-0c6312b165804482aebc08a542b1389d"> 11 (26.82%)</p>
              </td>
              <td id="table-cell-a8347a76e51c413eabcc257e901041d2" rowspan="3" align="left">
                <p id="paragraph-9723e209463a4bcba73cdc323040a7b0"> 0.678</p>
              </td>
              <td id="table-cell-ba594a77b1e14960ac2e9598672f966d" rowspan="3" align="left">
                <p id="paragraph-59fe7fc3b7e441cb8019e11903405324"> Good agreement</p>
              </td>
            </tr>
            <tr id="table-row-77f0e13a68a84149a2dc709a6d9f1635">
              <td id="table-cell-656499fc4d4145b39b4e8f079f7caf03" align="left">
                <p id="paragraph-c65a997daddc423bbd3bb8d4f299e437"> 1.1</p>
              </td>
              <td id="table-cell-8abbe231f64e4305b595fd4f78a19804" align="left">
                <p id="paragraph-7aaa6bfc1c094127bc45f4ba74f52e3c"> 20 (48.78%)</p>
              </td>
              <td id="table-cell-74e160a7edcc44138253e1210cf4ed74" align="left">
                <p id="paragraph-914568c433454bd0bcb8e91cfc72211e"> 15 (36.58%)</p>
              </td>
            </tr>
            <tr id="table-row-8e3112a4d2b042889f96cd06f9171de7">
              <td id="table-cell-b29bfe522ce745fe8fd4596b361cee07" align="left">
                <p id="paragraph-a494c416a2024c8bb55c70ccc0175029"> 1.2</p>
              </td>
              <td id="table-cell-77c184c71dec4fbe85c885de4a72af34" align="left">
                <p id="paragraph-fd50ca00a5f649aaa0f12219f5623a06"> 12 (29.26%)</p>
              </td>
              <td id="table-cell-a1e35d6c6e9c4632a17ee837960f1078" align="left">
                <p id="paragraph-89ced2168ef9443abfe7558df18efbe1"> 12 (29.26%)</p>
              </td>
            </tr>
            <tr id="table-row-f75fbd7001e4466eb3731755eec540c1">
              <td id="table-cell-1da98ff9091540e6a896ee19a7cd3e6b" colspan="5" align="left">
                <p id="paragraph-a8c6e7d265174a84bedb81160aaeb643"> <bold id="strong-f4b0a3c9f54d41249254301d3cd38afd">Grade 2A:</bold> Eosinophils in lamina propria</p>
              </td>
            </tr>
            <tr id="table-row-bf28167b5794472da492d85f96a12d06">
              <td id="table-cell-e4b2f3447f654a78a4e64ead7e531255" align="left">
                <p id="paragraph-e4fa0a58512c4f89910853ed9c7b63c7"> 2A.0</p>
              </td>
              <td id="table-cell-bdcc4f83899540f798bab18c26e92c9d" align="left">
                <p id="paragraph-55d6d4bdf62e4f42869eeffbf5519fef"> 14 (34.14%)</p>
              </td>
              <td id="table-cell-9c4f2b932c834a5d9a485e7087157a58" align="left">
                <p id="paragraph-1e00991c9f084bfe9d51f8fb70924404"> 19 (46.83%)</p>
              </td>
              <td id="table-cell-afb8cff817d945faab9c005e491dda81" rowspan="3" align="left">
                <p id="paragraph-b68786da74724d47a804da7021bea21f"> 0.532</p>
              </td>
              <td id="table-cell-3f41be3e5f424065b4e79279475032e9" rowspan="3" align="left">
                <p id="paragraph-0e7c021c8582425ba9f4e8b617b6b6ac"> Moderate agreement</p>
              </td>
            </tr>
            <tr id="table-row-81f63064e950420099196af6f609f63a">
              <td id="table-cell-d18139754a7041a59e4fbe748cb9bbd7" align="left">
                <p id="paragraph-e1226b65c82c44458866f02a10dd3347"> 2A.1</p>
              </td>
              <td id="table-cell-0072ea95e92143f2a2b768cbd87579ee" align="left">
                <p id="paragraph-46d7bce1176d4723ab8bc1ca16bc2451"> 21 (51.21%)</p>
              </td>
              <td id="table-cell-b8f73db5e4354b45adb5c8c64faf26e4" align="left">
                <p id="paragraph-d557b061f4f1455597931053afcb7c0f"> 13 (31.70%)</p>
              </td>
            </tr>
            <tr id="table-row-98be86884ae747069f59968d1e1eebfb">
              <td id="table-cell-b24bdb3bf2504e3088dbffd299d38900" align="left">
                <p id="paragraph-f23918ad512f47888fc9a2da9fea8308"> 2A.2</p>
              </td>
              <td id="table-cell-9c98aa8a4ed54a119415942deb1e7a73" align="left">
                <p id="paragraph-2c21f9c0f7284e3c84f41e09b63106e0"> 6 (14.63%)</p>
              </td>
              <td id="table-cell-42333f4fde9b4e07a5398427aa046eab" align="left">
                <p id="paragraph-aaa723249c5741e2b99efa82750a7ddd"> 6 (14.63%)</p>
              </td>
            </tr>
            <tr id="table-row-cec5f02f985947e7a011b1b56c76fa93">
              <td id="table-cell-e3405ec2b9e049a4a4eb83649fcc2108" colspan="5" align="left">
                <p id="paragraph-8e1c350a3bd54ced8d4d059049998254"> <bold id="strong-6e2e50b745074ed9bf4c1cfab0c8b806">Grade 2B:</bold> Neutrophils in lamina propria</p>
              </td>
            </tr>
            <tr id="table-row-9baeb63fbfdc4c18b8b933c85b6fe696">
              <td id="table-cell-e99ec108e2e44bf4af426c1f8880c39c" align="left">
                <p id="paragraph-7667dcfbdf064bd58278fb8c0f3b3db4"> 2B.0</p>
              </td>
              <td id="table-cell-0b6f89af93ab4fb08046b51515be17c8" align="left">
                <p id="paragraph-d8c7d5b175214739bb103ac07ee3ab4c"> 4 (9.75%)</p>
              </td>
              <td id="table-cell-54868919ef6d446e88e1d99d7322a3e7" align="left">
                <p id="paragraph-9fac9e7c5ddb48979df3b2ce1e016e9e"> 8 (19.56%)</p>
              </td>
              <td id="table-cell-a225a1f3bc624951ad74c939a6caa3e1" rowspan="3" align="left">
                <p id="paragraph-69fe8008b7a64d93ae6393e1b5a0df87"> 0.659</p>
              </td>
              <td id="table-cell-0197bf5199d94b4198955a035110fff3" rowspan="3" align="left">
                <p id="paragraph-5c5f4cfad43e4e428c3a1db8b0bac653"> Good agreement</p>
              </td>
            </tr>
            <tr id="table-row-962719773ace4f94b6c35860f8951253">
              <td id="table-cell-e3afc6dbde424714911f3117b54bb27f" align="left">
                <p id="paragraph-bc4daf9a52c1415ca0cea57d012ecdff"> 2B.1</p>
              </td>
              <td id="table-cell-959380b0149841e88280879dab5e2e6f" align="left">
                <p id="paragraph-91cc82d392fd442a9df8cec0c082d315"> 25 (60.97%)</p>
              </td>
              <td id="table-cell-cef1cbe998cd430c8d76ffdd0a6c25bc" align="left">
                <p id="paragraph-1041aa25ecec44e1a3a044cf34a1f76b"> 7 (41.46%)</p>
              </td>
            </tr>
            <tr id="table-row-5436fde9a8d9455eb2f8212b8427adc0">
              <td id="table-cell-7612fe442dcf4e72a249cc8f142460ec" align="left">
                <p id="paragraph-904c497c01324364a7d6d806bed3b2a3"> 2B.2</p>
              </td>
              <td id="table-cell-ca2ff2be1bb649938a2100888bb5a12d" align="left">
                <p id="paragraph-219ed08647f842e0924bd1e18b590d0e"> 12 (29.26%)</p>
              </td>
              <td id="table-cell-05aa623e01bb43ef89ba99546a636282" align="left">
                <p id="paragraph-3979bc90f806443a90cd442da61455b2"> 13 (31.70%)</p>
              </td>
            </tr>
            <tr id="table-row-6f99a43e295d485a81c4f87b65a857a9">
              <td id="table-cell-3993cb46d7104e1bbc381ed4a3ed2fab" colspan="5" align="left">
                <p id="paragraph-002d46c596da43ecbcf642b741555aaa"> <bold id="strong-c8f873d2a22f41568a5cb2e29c9a54da">Grade 3:</bold> Neutrophils in epithelium</p>
              </td>
            </tr>
            <tr id="table-row-dfd5477d937640d78821d1cecb252ebd">
              <td id="table-cell-b91a87a413e644cdb254223108ecdfc4" align="left">
                <p id="paragraph-074a4fa238bd4d7c96d7cf27775c3eb7"> 3.0</p>
              </td>
              <td id="table-cell-5025f4e0dcd8446aa2e8eacff7262c51" align="left">
                <p id="paragraph-b4b0625123724fc5b2a154ed850225c0"> 3 (7.31%)</p>
              </td>
              <td id="table-cell-853402a57bd54c36b2c99659155b8315" align="left">
                <p id="paragraph-08449a0403b94ee287114e90ca5db4b9"> 4 (9.75%)</p>
              </td>
              <td id="table-cell-978c141a57494f879f2b45daecf834ef" rowspan="3" align="left">
                <p id="paragraph-a2ffcd5496074175bc9f27ee00d97a6c"> 0.678</p>
              </td>
              <td id="table-cell-160177538d024406a37772f486850e50" rowspan="3" align="left">
                <p id="paragraph-dae067af80bb48bcb00a8bcac149c9c5"> Good agreement</p>
              </td>
            </tr>
            <tr id="table-row-cf4c4dec9d5848d1a6d90b20abe7454a">
              <td id="table-cell-517f4761de4548ec872ab0ad2da94129" align="left">
                <p id="paragraph-7531cab292a3491fa8f459f13d963b9e"> 3.1</p>
              </td>
              <td id="table-cell-3ce29070e3d845acaf4b535973d89cc7" align="left">
                <p id="paragraph-5908b6618f8e44c7bdab671f5b7728b9"> 34 (82.92%)</p>
              </td>
              <td id="table-cell-706ed14ffa57495298edde0233284ef3" align="left">
                <p id="paragraph-e40f91605b544a6faca830341f5cc18b"> 6 (14.63%)</p>
              </td>
            </tr>
            <tr id="table-row-c19457e07263452291a720e74e4fb89b">
              <td id="table-cell-58766fb9ad9f4a28be52d0f6087b1bd6" align="left">
                <p id="paragraph-0fb882168c7d49299a191d5b9d606cfc"> 3.2</p>
              </td>
              <td id="table-cell-976f84b7125a45cc84dd9072379921ad" align="left">
                <p id="paragraph-62061184297547c88d8c9072567052ca"> 4 (9.75%)</p>
              </td>
              <td id="table-cell-93d455e880cb47d0b9c7017adf84cf78" align="left">
                <p id="paragraph-c95e865dda6a4b5d84ec8f3287bdecf3"> 31 (75.60%)</p>
              </td>
            </tr>
            <tr id="table-row-a905050612aa440aaeb0409ac271abe8">
              <td id="table-cell-87b365c456fb441ba8037541e9dde8ef" colspan="5" align="left">
                <p id="paragraph-1d34d20ca06845f5887ee5fcc0b62bd3"> <bold id="strong-0e6e5cc93ae44712bd44dedc551c08d5">Grade 4:</bold> Epithelial injury (in crypt and surface epithelium)</p>
              </td>
            </tr>
            <tr id="table-row-d7500e7e5d7346e18a754de46c945d83">
              <td id="table-cell-5160b07191fc4fc3be7ed479715a89ae" align="left">
                <p id="paragraph-85d3a4bc83bc4b6681526c15d874eacf"> 4.0</p>
              </td>
              <td id="table-cell-b90a2e2e255a4975982ed0cc5cc5a2ae" align="left">
                <p id="paragraph-b223806d7c634327bcdb17b312820305"> 3 (7.3%)</p>
              </td>
              <td id="table-cell-215265914c624e80b0d69e4678139960" align="left">
                <p id="paragraph-a3a583ad0e5b41e29a8f96d6965f8b8f"> 6 (14.63%)</p>
              </td>
              <td id="table-cell-6438e8189597488da08c06ad53addb64" rowspan="5" align="left">
                <p id="paragraph-1cec45e1c89445e99299f0cc4535c975"> 0.335</p>
              </td>
              <td id="table-cell-f9704ec219fc41d8869d2cf7ba6f0cbe" rowspan="5" align="left">
                <p id="paragraph-5b7c2a73a52344349606416db723ff99"> Low agreement</p>
              </td>
            </tr>
            <tr id="table-row-7527028aff144688bca760d2786e2c7e">
              <td id="table-cell-99f852310a4b435aa2a91ce1487642b0" align="left">
                <p id="paragraph-591e22e18f314c5a972366f549984127"> 4.1</p>
              </td>
              <td id="table-cell-740378a96a404ef2888429fe4baade70" align="left">
                <p id="paragraph-9ed51068f1f54a9f9ba352b6b58dc73c"> 0</p>
              </td>
              <td id="table-cell-dc136d84fee04b4b8a3b061f21b3c084" align="left">
                <p id="paragraph-205a1688fff8498287ee985909af3289"> 3 (7.3%)</p>
              </td>
            </tr>
            <tr id="table-row-c9c6cb1538cf4b2483ff1b58708a094b">
              <td id="table-cell-95c8a3a159a544d293c8e0f53bc0a9e8" align="left">
                <p id="paragraph-32d9004d48764879b6eea924c90cb1c1"> 4.2</p>
              </td>
              <td id="table-cell-c13fbbe1a9a843d0a9a0b1e05b5fc120" align="left">
                <p id="paragraph-3dc78261899c4b168566f9df0f2cf837"> 16 (39.02%)</p>
              </td>
              <td id="table-cell-862dd682271d4595ac942400589c2c59" align="left">
                <p id="paragraph-063cd75e0a7b4fd2aba1dfabdd6d7c76"> 19 (46.34%)</p>
              </td>
            </tr>
            <tr id="table-row-afa37c685c14423f82fca873fb412b58">
              <td id="table-cell-c696411df0aa406b872fe25f8b349257" align="left">
                <p id="paragraph-1a9b29ae3a3d4b4596a90afce9bc2459"> 4.3</p>
              </td>
              <td id="table-cell-163c2d309eb94343ab9136a165317fea" align="left">
                <p id="paragraph-92c65333855644d59ee7a84dc2bddf46"> 13 (31.70%)</p>
              </td>
              <td id="table-cell-8d3fb9f6bc514d1da46c3c560719eb21" align="left">
                <p id="paragraph-400e0ce271794a20b48d03772e388f36"> 6 (14.63%)</p>
              </td>
            </tr>
            <tr id="table-row-7bb9afbf21c846c7841b9a47aba87f80">
              <td id="table-cell-fe0ea2e2289f46269d35422c10a11ce8" align="left">
                <p id="paragraph-73d1c3c0bd414f358d1066e3831bd9db"> 4.4</p>
              </td>
              <td id="table-cell-141a542d13bf4d15b20947d9da105ff1" align="left">
                <p id="paragraph-f04e178971114c689e55dfb9d186f07e"> 9 (21.95 %)</p>
              </td>
              <td id="table-cell-1087a6cb928a44b29d034383e88d124a" align="left">
                <p id="paragraph-3ad0e6e0f3654837a80926922f1cac0e"> 7 (17.07%)</p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig id="figure-7106e75d8ec8437ca0ed25aa3e7b9455" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 1 </label>
        <caption id="caption-42049b9940804b76ac6aaa4c10ba6fdc">
          <title id="title-2e79f9af059d4aadbdd9134c39cc6572"><bold id="s-293ffc40551d">Crypt</bold> <bold id="s-9cba839165b7">architectural changes, Grade 0 </bold></title>
        </caption>
        <graphic id="graphic-d4930dc8ba6645bf944f97887b7ef08d" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/1f36b45b-eb5d-49c9-843f-4faebb2ccc3eimage1.jpeg"/>
      </fig>
      <fig id="figure-4dca2914f676454abc321cafd965b673" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 2 </label>
        <caption id="caption-29cdfefc458d4352a6c10a159363d7d0">
          <title id="title-70b3de9f44af444ca0fb7af52296243d">
            <bold id="s-8512f5bc1561">Basal plasmacytosis, Grade 1. (400x. H &amp; E)</bold>
          </title>
        </caption>
        <graphic id="graphic-04ca461dc041425f953eff9c61f1196c" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/1f36b45b-eb5d-49c9-843f-4faebb2ccc3eimage2.jpeg"/>
      </fig>
      <p id="p-8f2c71223857"/>
      <fig id="f-77d6f9f01588" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 3 </label>
        <caption id="c-20ffd46082f4">
          <title id="t-c32cab712ac4">
            <bold id="s-43d44f4a43d1">Eosinophils in lamina propria (Grade 2A)</bold>
          </title>
        </caption>
        <graphic id="g-ccd92a9c02da" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e952a535-fcb4-496f-a824-9d4d996e71f2/image/f0d07a86-8954-4e69-9940-3ae0096d391c-uimage.png"/>
      </fig>
      <p id="p-3f8a2bde0dd6"/>
      <p id="p-b92c9ff12628"/>
      <fig id="f-a423ed9fc60d" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 4 </label>
        <caption id="c-532d8dc409ba">
          <title id="t-0d1d64551cc3">
            <bold id="s-7678010ff93d">Neutrophils in the epithelium and crypts (Grade 2b, 3)</bold>
          </title>
        </caption>
        <graphic id="g-6bcb831167a7" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/e952a535-fcb4-496f-a824-9d4d996e71f2/image/6d46cd86-c53f-4783-a6f1-b0275d62fe16-uimage.png"/>
      </fig>
      <p id="p-363552fdd5fe"/>
      <p id="paragraph-ec7564a9d6d245ba8e645a4434d94def">The agreement for the detection of histologic activity (score ≥3.1) using was compared between both the pathologists using kappa coefficient. Of the 41 cases, Pathologist 1 scored 38 cases (92.68%) as histologically active disease and 3 cases (7.3%) as inactive. Whereas Pathologist 2, scored 35 cases (85.3%) as histologically active disease and 6 cases (14.63%) as inactive disease. This showed good agreement with kappa coefficient of 0.678. A total of 3 cases (7.3%) showed no correlation between both pathologists in assessing histologic activity.</p>
    </sec>
    <sec>
      <title id="title-afccd57d98bb44f5ae238a11eeec59e6">Discussion</title>
      <p id="paragraph-d20b4082308c46b286289ba5dec9c52f">Over the years histologic healing has slowly replaced clinical and endoscopic healing to become the targeted therapeutic goal in UC <xref id="xref-027fcbcda42a4201bb671b05c4edbbee" rid="R224913830271265" ref-type="bibr">9</xref>. The absence of histologic healing, makes patients prone to develop recurrences/ relapses and also confers them to an increased risk of dysplasia <xref id="xref-9457ce2ed3d54cd7b5fe6a4f1bc0d6e6" rid="R224913830271269" ref-type="bibr">10</xref>. An interest in histologic inflammation was seen as early as 1966, when Wright and Truelove attributed persistent histologic inflammation to poor clinical outcomes even with endoscopically normal mucosa <xref id="xref-535a0ba785b040b99731b458ba16a9f5" rid="R224913830271268" ref-type="bibr">4</xref>. In 1991, 25yrs later, Riley et al, demonstrated that active inflammation on histology is associated with disease relapse among patients in remission <xref id="xref-2082cb8dbd124ee882e8e7254449bf69" rid="R224913830271270" ref-type="bibr">3</xref>. Ever since, many researchers have studied the association between different histologic parameters and relapse/ refractoriness to therapy. Thus, many scoring systems came into existence. Among the 30 scoring systems available for grading UC some are complex to use and only a few have been validated- one such score is Geboes score <xref id="xref-0dad20c268894f2db10909cf32190048" rid="R224913830271264" ref-type="bibr">11</xref>. Though the scoring systems have been used extensively in clinical trials, their use in routine reporting is limited mainly due to their complexity and interobserver variability <xref id="xref-17ef1d06978f45d0bf90529dc0444e85" rid="R224913830271274" ref-type="bibr">12</xref>. Therefore, assessment of interobserver variability becomes essential to rely on reproducibility. Other scoring system used for UC is Nancy Index (NI) and Robarts Histopathology Index (RHI). NI is the simplest scoring system to use but it doesn't evaluate important prognostic parameters like basal plasmacytosis, increase in eosinophils and structural changes<bold id="strong-33c1b76172634834b0c63d118de4831d">.</bold> Robart’s Histopathological Index (RHI) has a better definition of parameters which makes it a better scoring system over GS for routine use. It also evaluates basal plasmacytosis which is an important prognostic parameter. Unlike GS, it does not evaluate increase in eosinophils</p>
      <p id="paragraph-b347f2c0e2014eb7b4f051a8bf9c3584">Amezaga et al, reviewed 103 biopsies using Original Geboes Score (OGS) and SGS. These histological scores were each compared with Mayo Endoscopic subscores. They further studied interobserver agreement for both OGS and SGS between 3 trained readers with experienced Gastropathologists. The interobserver agreement showed moderate agreement for all grades of SGS and also OGS except for grade 2B where it showed low agreement <xref id="xref-02421bfb6aaa49578579101925ec1cfb" rid="R224913830271281" ref-type="bibr">5</xref>.</p>
      <p id="paragraph-82f1d0a3b51b4c03923205a7d6466e02">The current study showed poor agreement for Grade 4, moderate for Grade 0 and Grade 2A, whereas good agreement was noted for Grades 1, 2B and 3 (<xref id="x-21b432d2484a" rid="table-wrap-a2decfddb58e44bc817658d58b7726ca" ref-type="table">Table 2</xref>). Each of the individual parameters in SGS have their own relevance in disease monitoring as discussed below.</p>
      <p id="paragraph-989e0d3699a04f5c8b8a373a2ffc7644">Grade 0- No inflammatory activity with architectural changes: This is characterized by features such as branching crypts with loss of parallelism, crypt shortening, crypt loss and atrophy <xref id="xref-900338d2351a4af297785a574dc73230" rid="R224913830271277" ref-type="bibr">13</xref>. These features may be seen even in complete remission and their persistence in patients on clinical remission/ mucosal healing is predictive of relapse within short time period <xref id="xref-812cfc5d576d475698dda80439d5f4e0" rid="R224913830271273" ref-type="bibr">14</xref>.</p>
      <p id="paragraph-bea14aefa9d5402296a9448cd2fb99e3">Grade 1- Basal plasmacytosis: It is defined by expansion of the space between the base of the crypts and muscularis mucosae by plasma cells <xref id="xref-ec4770be76bf476b94ded00c4f67fb80" rid="R224913830271276" ref-type="bibr">6</xref>. BP has been confirmed and validated by various studies as an early diagnostic feature and also an important prognostic factor. The persistence of BP during remission can predict disease relapse, especially in asymptomatic cases. Basal plasmacytosis as a parameter is also being used in other scoring systems like Robart’s Histopathology Index, which is derived from Geboes Score <xref id="xref-ddb8d75edeb94a3c80814d0cbced899a" rid="R224913830271263" ref-type="bibr">15</xref>.</p>
      <p id="paragraph-bdb738f1cce34836a8f5b5c598c60d99">Grade 2A- Eosinophils in lamina propria: Eosinophils in the lamina propria are normally present in the colon and more so in the right colon <xref id="xref-08d313a44f2546dab26de76962d17250" rid="R224913830271280" ref-type="bibr">16</xref>. They also show geographic and seasonal variations. There is no definite criteria as to what exactly constitutes increased eosinophils. A good knowledge of histology is therefore crucial for interpretation of eosinophils. Similar to current study, other studies have also shown only a moderate inter observer agreement <xref id="xref-0f3c4025385b4e75836712921a62c740" rid="R224913830271279" ref-type="bibr">17</xref>. Eosinophils may be increased in both active and quiescent disease <xref id="xref-7b768a54b0024996b945b65abb4b6caa" rid="R224913830271278" ref-type="bibr">18</xref>. Increased eosinophils are also seen to be associated with relapses, indicate non responsiveness to therapy. They are also known to constitute a high risk towards the development of fibrosis and stenosis <xref id="xref-bad658b34d6e48f6b69aef9091a89dc1" rid="R224913830271266" ref-type="bibr">19</xref>.</p>
      <p id="paragraph-8691a5e01bdb4454875231d9ebd356b5">Grade 2B and Grade 3-Neutrophils in the lamina propria and in the epithelium: The colonic mucosa usually does not show any neutrophils, so the presence of neutrophils either in lamina propria or epithelium is abnormal. As per, the RAND consensus even the presence of two neutrophils in the colonic mucosa constitutes active inflammation <xref id="xref-c5af52de21584d96b2689291ec4930cd" rid="R224913830271268" ref-type="bibr">4</xref>. Also, persistence of activity among the patients on treatment is said to be associated with poor clinical outcomes as well as relapses <xref id="xref-efd52bda2e954b3899c92fb38c8349c8" rid="R224913830271276" ref-type="bibr">6</xref>. Lobaton et al, noted that a combination of basal plasmacytosis and intraepithelial neutrophils showed a strong association with disease relapse <xref id="xref-a65eee3418424e15bf8e443bcb213b59" rid="R224913830271269" ref-type="bibr">10</xref>. Few studies have also shown that persistence of cryptitis and crypt abscess are predictors of an aggressive and refractory disease <xref id="xref-6467ed0f7d024c1a9df5da3c607a2328" rid="R224913830271265" ref-type="bibr">9</xref>.</p>
      <p id="paragraph-23d5181134ad4645ac2a1cf6347c1c6f">Grade 4, Epithelial injury (in crypts and surface epithelium). A marked variation was noted in grading Grade 4.1 between both the pathologists. Pathologist 1 did not notice marked attenuation of crypts in any of the biopsies, whereas Pathologist 2 noticed the same in 3 (7.3%) cases. The grading lacks precise defining criteria for 4.1. This could have been the cause for subjectivity between both the pathologists. It could have been improved by prior discussions between both the pathologists on arriving at precise definitions for Grade 4.1.</p>
      <sec>
        <title id="t-87a0cdb012c5">Histologic activity</title>
        <p id="paragraph-d6df6d64e83e461b83564d6d42457836">The current study showed substantial agreement for histologic activity (&gt;3.1) as shown in <xref id="x-a6d06488c6b3" rid="table-wrap-a2decfddb58e44bc817658d58b7726ca" ref-type="table">Table 2</xref>, whereas Amezaga et.al showed moderate agreement <xref id="xref-3df25abe8ab9431cb21877168be95ae0" rid="R224913830271281" ref-type="bibr">5</xref>. The presence of even two neutrophils in the colonic mucosa is considered activity <xref id="xref-59327179a50149728707ba13fc5ab6f5" rid="R224913830271265" ref-type="bibr">9</xref>.</p>
        <p id="paragraph-a87e6a13758145278ecf369900a835ff">A total of 3 cases (7.3%) showed no correlation between both pathologists in assessing histologic activity. Here pathologist 2 graded all three cases as absence of neutrophils in epithelium (Grade &lt;3.1) while Pathologist1 graded them as active (Grade ≥3.1). This could be due to lack of adequate screening, thus neglecting the presence of occasional neutrophils.</p>
        <p id="paragraph-64b15a597c7d4edb87c81c2932f23016">Mucosal healing on endoscopy is not the therapeutic end point, instead it is histologic healing as observed on biopsy. Thus, it is recommended to biopsy the colon for microscopic evaluation in all UC, even in those with endoscopically normal mucosa <xref id="xref-3366042d1b7e42eb93d54c9dfed95408" rid="R224913830271274" ref-type="bibr">12</xref>. Also, considering the impact of identification of various histologic parameters on disease prognosis and treatment responses, it is valuable to adopt these in routine scoring of all biopsies of UC. </p>
        <p id="paragraph-e1bd77269dc54621b6bfadbf53b4e8a8">The current study is limited by evaluation of slides by only two pathologists. Study of slides by more pathologists with assessment of interobserver agreement would have added more credibility<bold id="strong-27d1801ff7a1485e9cfbde0f974f9479">.</bold></p>
      </sec>
    </sec>
    <sec>
      <title id="title-88ef4d12ed70406c84ead0715f398c15">Conclusion</title>
      <p id="paragraph-e3d84938b4614fad9e5886fde448b8bd">Over the years, Histologic healing has replaced mucosal healing as the therapeutic endpoint in UC. Various histologic parameters have their own significance in predicting treatment outcomes and prognosis. Thus, adopting a standard scoring system for routine histopathological reporting of all cases is essential. The SGS is simple to use and shows good interobserver agreement for histological activity and moderate to good agreement for individual grades. Therefore, it can be adopted for routine reporting of all biopsies in Ulcerative Colitis. </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R224913830271267">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>Dae Bum</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Kang-Moon M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Ji Min</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>Yoon Yung</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>Hea Jung</given-names>
            </name>
            <name>
              <surname>Paik</surname>
              <given-names>Chang Nyol</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>Woo Chul</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>Ji-Han</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>Hyun Joo</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Correlation between Histological Activity and Endoscopic, Clinical, and Serologic Activities in Patients with Ulcerative Colitis</article-title>
          <source>Gastroenterology Research and Practice</source>
          <year>2016</year>
          <volume>2016</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <issn>1687-6121</issn>
          <publisher-name>Hindawi Limited</publisher-name>
          <uri>https://doi.org/10.1155/2016/5832051</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271272">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Turner</surname>
              <given-names>J R</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Abbas</surname>
              <given-names>A K</given-names>
            </name>
            <name>
              <surname>Aster</surname>
              <given-names>J C</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>J R</given-names>
            </name>
            <collab/>
          </person-group>
          <person-group person-group-type="editor"/>
          <article-title>Robbins and Cotran Pathologic basis of disease</article-title>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>Philadelphia</publisher-loc>
          <year>2020</year>
          <fpage>802</fpage>
          <lpage>803</lpage>
        </element-citation>
      </ref>
      <ref id="R224913830271270">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosli</surname>
              <given-names>Mahmoud H</given-names>
            </name>
            <name>
              <surname>Samaan</surname>
              <given-names>Mark</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>Sigrid A</given-names>
            </name>
            <name>
              <surname>Feagan</surname>
              <given-names>Brian G</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>Simon</given-names>
            </name>
            <name>
              <surname>D&amp;apos;haens</surname>
              <given-names>Geert</given-names>
            </name>
            <name>
              <surname>Sandborn</surname>
              <given-names>William J</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>G Y</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>John K</given-names>
            </name>
            <name>
              <surname>Levesque</surname>
              <given-names>Barrett G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis</article-title>
          <source>Cochrane Database of Systematic Reviews</source>
          <year>2017</year>
          <fpage>1</fpage>
          <lpage>34</lpage>
          <publisher-name>Wiley</publisher-name>
          <uri>https://doi.org/10.1002/14651858.CD011450.pub2</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271268">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pai</surname>
              <given-names>Rish K</given-names>
            </name>
            <name>
              <surname>Jairath</surname>
              <given-names>Vipul</given-names>
            </name>
            <name>
              <surname>Casteele</surname>
              <given-names>Niels Vande</given-names>
            </name>
            <name>
              <surname>Rieder</surname>
              <given-names>Florian</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>Claire E</given-names>
            </name>
            <name>
              <surname>Lauwers</surname>
              <given-names>Gregory Y</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>The emerging role of histologic disease activity assessment in ulcerative colitis</article-title>
          <source>Gastrointestinal Endoscopy</source>
          <year>2018</year>
          <volume>88</volume>
          <issue>6</issue>
          <fpage>887</fpage>
          <lpage>898</lpage>
          <issn>0016-5107</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.gie.2018.08.018</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271281">
        <element-citation publication-type="misc">
          <person-group person-group-type="author">
            <name>
              <surname>Amezaga</surname>
              <given-names>A J</given-names>
            </name>
            <name>
              <surname>Geerits</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lemmens</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sagaert</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bessissow</surname>
              <given-names>T</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>A Simplified GeboesScore for Ulcerative Colitis</article-title>
          <year>2017</year>
          <fpage>305</fpage>
          <lpage>313</lpage>
          <uri>https://doi.org/10.1093/ecco-jcc/jjw154</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271276">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liverani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Scaioli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Digby</surname>
              <given-names>R J</given-names>
            </name>
            <name>
              <surname>Bellanova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Belluzzi</surname>
              <given-names>A</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>How to predict clinical relapse in inflammatory bowel disease patients</article-title>
          <source>World Journal of Gastroenterology</source>
          <year>2016</year>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>1017</fpage>
          <lpage>1017</lpage>
          <issn>1007-9327</issn>
          <publisher-name>Baishideng Publishing Group Inc.</publisher-name>
          <uri>https://doi.org/10.3748/wjg.v22.i3.1017</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271271">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patil</surname>
              <given-names>D T</given-names>
            </name>
            <name>
              <surname>Odze</surname>
              <given-names>R D</given-names>
            </name>
            <name>
              <surname/>
              <given-names>J R Goldblum</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Inflammatory Disorder Of Large Intestine</article-title>
          <source>Surgical Pathology of the GI tract, Liver, Biliary tract and Pancreas</source>
          <volume>2023</volume>
          <fpage>496</fpage>
          <lpage>582</lpage>
          <publisher-name>Elsevier</publisher-name>
        </element-citation>
      </ref>
      <ref id="R224913830271275">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosli</surname>
              <given-names>Mahmoud H</given-names>
            </name>
            <name>
              <surname>Feagan</surname>
              <given-names>Brian G</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>Guangyong</given-names>
            </name>
            <name>
              <surname>Sandborn</surname>
              <given-names>William J</given-names>
            </name>
            <name>
              <surname>D&amp;apos;haens</surname>
              <given-names>Geert</given-names>
            </name>
            <name>
              <surname>Khanna</surname>
              <given-names>Reena</given-names>
            </name>
            <name>
              <surname>Shackelton</surname>
              <given-names>Lisa M</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>Christopher W</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>Sigrid</given-names>
            </name>
            <name>
              <surname>Vandervoort</surname>
              <given-names>Margaret K</given-names>
            </name>
            <name>
              <surname>Frisbie</surname>
              <given-names>Valerie</given-names>
            </name>
            <name>
              <surname>Samaan</surname>
              <given-names>Mark A</given-names>
            </name>
            <name>
              <surname>Jairath</surname>
              <given-names>Vipul</given-names>
            </name>
            <name>
              <surname>Driman</surname>
              <given-names>David K</given-names>
            </name>
            <name>
              <surname>Geboes</surname>
              <given-names>Karel</given-names>
            </name>
            <name>
              <surname>Valasek</surname>
              <given-names>Mark A</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>Rish K</given-names>
            </name>
            <name>
              <surname>Lauwers</surname>
              <given-names>Gregory Y</given-names>
            </name>
            <name>
              <surname>Riddell</surname>
              <given-names>Robert</given-names>
            </name>
            <name>
              <surname>Stitt</surname>
              <given-names>Larry W</given-names>
            </name>
            <name>
              <surname>Levesque</surname>
              <given-names>Barrett G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Development and validation of a histological index for UC</article-title>
          <source>Gut</source>
          <year>2017</year>
          <volume>66</volume>
          <issue>1</issue>
          <fpage>50</fpage>
          <lpage>58</lpage>
          <issn>0017-5749</issn>
          <publisher-name>BMJ</publisher-name>
          <uri>https://doi.org/10.1136/gutjnl-2015-310393</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271265">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vespa</surname>
              <given-names>Edoardo</given-names>
            </name>
            <name>
              <surname>D’amico</surname>
              <given-names>Ferdinando</given-names>
            </name>
            <name>
              <surname>Sollai</surname>
              <given-names>Mauro</given-names>
            </name>
            <name>
              <surname>Allocca</surname>
              <given-names>Mariangela</given-names>
            </name>
            <name>
              <surname>Furfaro</surname>
              <given-names>Federica</given-names>
            </name>
            <name>
              <surname>Zilli</surname>
              <given-names>Alessandra</given-names>
            </name>
            <name>
              <surname>Buono</surname>
              <given-names>Arianna Dal</given-names>
            </name>
            <name>
              <surname>Gabbiadini</surname>
              <given-names>Roberto</given-names>
            </name>
            <name>
              <surname>Danese</surname>
              <given-names>Silvio</given-names>
            </name>
            <name>
              <surname>Fiorino</surname>
              <given-names>Gionata</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art</article-title>
          <source>Journal of Clinical Medicine</source>
          <year>2022</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>939</fpage>
          <lpage>939</lpage>
          <publisher-name>MDPI AG</publisher-name>
          <uri>https://doi.org/10.3390/jcm11040939</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271269">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lobaton</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bessissow</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cerulla</surname>
              <given-names>A R</given-names>
            </name>
            <name>
              <surname>Hertogh</surname>
              <given-names>G D</given-names>
            </name>
            <name>
              <surname>Bisschops</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guardia</surname>
              <given-names>J</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicentric study</article-title>
          <source>United European gastroenterol</source>
          <year>2018</year>
          <volume>6</volume>
          <issue>5</issue>
          <fpage>765</fpage>
          <lpage>772</lpage>
          <uri>https://doi.org/10.1177/2050640617752207</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271264">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosli</surname>
              <given-names>M H</given-names>
            </name>
            <name>
              <surname>Feagan</surname>
              <given-names>B G</given-names>
            </name>
            <name>
              <surname>Sandborn</surname>
              <given-names>W J</given-names>
            </name>
            <name>
              <surname>Haens</surname>
              <given-names>G D</given-names>
            </name>
            <name>
              <surname>Behling</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>K</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Histological Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices</article-title>
          <source>Inflamm Bowel Dis</source>
          <year>2014</year>
          <volume>20</volume>
          <issue>3</issue>
          <fpage>564</fpage>
          <lpage>575</lpage>
        </element-citation>
      </ref>
      <ref id="R224913830271274">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geboes</surname>
              <given-names>K</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Histopathology of Crohn’s disease and ulcerative colitis</article-title>
          <source>Inflamma bowel dis</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>210</fpage>
          <lpage>218</lpage>
          <uri>https://www.researchgate.net/publication/242114322_Histopathology_of_Crohn's_disease_and_ulcerative_colitis</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271277">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feagins</surname>
              <given-names>Linda A</given-names>
            </name>
            <name>
              <surname>Melton</surname>
              <given-names>Shelby D</given-names>
            </name>
            <name>
              <surname>Iqbal</surname>
              <given-names>Ramiz</given-names>
            </name>
            <name>
              <surname>Dunbar</surname>
              <given-names>Kerry B</given-names>
            </name>
            <name>
              <surname>Spechler</surname>
              <given-names>Stuart J</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Clinical Implications of Histologic Abnormalities in Colonic Biopsy Specimens from Patients with Ulcerative Colitis in Clinical Remission</article-title>
          <source>Inflammatory Bowel Diseases</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>7</issue>
          <fpage>1477</fpage>
          <lpage>1482</lpage>
          <issn>1078-0998</issn>
          <publisher-name>Oxford University Press (OUP)</publisher-name>
          <uri>https://doi.org/10.1097/MIB.0b013e318281f4ae</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271273">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bessissow</surname>
              <given-names>Talat</given-names>
            </name>
            <name>
              <surname>Lemmens</surname>
              <given-names>Bart</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>Marc</given-names>
            </name>
            <name>
              <surname>Bisschops</surname>
              <given-names>Raf</given-names>
            </name>
            <name>
              <surname>Steen</surname>
              <given-names>Kristel Van</given-names>
            </name>
            <name>
              <surname>Geboes</surname>
              <given-names>Karel</given-names>
            </name>
            <name>
              <surname>Assche</surname>
              <given-names>Gert Van</given-names>
            </name>
            <name>
              <surname>Vermeire</surname>
              <given-names>Séverine</given-names>
            </name>
            <name>
              <surname>Rutgeerts</surname>
              <given-names>Paul</given-names>
            </name>
            <name>
              <surname>Hertogh</surname>
              <given-names>Gert De</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing</article-title>
          <source>American Journal of Gastroenterology</source>
          <year>2012</year>
          <volume>107</volume>
          <issue>11</issue>
          <fpage>1684</fpage>
          <lpage>1692</lpage>
          <issn>0002-9270</issn>
          <publisher-name>Ovid Technologies (Wolters Kluwer Health)</publisher-name>
          <uri>https://doi.org/10.1038/ajg.2012.301</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271263">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ozaki</surname>
              <given-names>Ryo</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>Taku</given-names>
            </name>
            <name>
              <surname>Okabayashi</surname>
              <given-names>Shinji</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>Masaru</given-names>
            </name>
            <name>
              <surname>Morinaga</surname>
              <given-names>Shojiroh</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>Atsuko</given-names>
            </name>
            <name>
              <surname>Ohbu</surname>
              <given-names>Makoto</given-names>
            </name>
            <name>
              <surname>Matsuoka</surname>
              <given-names>Kentaro</given-names>
            </name>
            <name>
              <surname>Toyonaga</surname>
              <given-names>Takahiko</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>Eiko</given-names>
            </name>
            <name>
              <surname>Hisamatsu</surname>
              <given-names>Tadakazu</given-names>
            </name>
            <name>
              <surname>Hibi</surname>
              <given-names>Toshifumi</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa</article-title>
          <source>Journal of Crohn's and Colitis</source>
          <year>2018</year>
          <volume>12</volume>
          <issue>11</issue>
          <fpage>1288</fpage>
          <lpage>1294</lpage>
          <issn>1873-9946</issn>
          <publisher-name>Oxford University Press (OUP)</publisher-name>
          <uri>https://doi.org/10.1093/ecco-jcc/jjy092</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271280">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conner</surname>
              <given-names>James R</given-names>
            </name>
            <name>
              <surname>Kirsch</surname>
              <given-names>Richard</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>The pathology and causes of tissue eosinophilia in the gastrointestinal tract</article-title>
          <source>Histopathology</source>
          <year>2017</year>
          <volume>71</volume>
          <issue>2</issue>
          <fpage>177</fpage>
          <lpage>199</lpage>
          <issn>0309-0167</issn>
          <publisher-name>Wiley</publisher-name>
          <uri> https://doi.org/10.1111/his.13228</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271279">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lampinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ronnblom</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Amin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kristjansson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rossman</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sangfelt</surname>
              <given-names>P</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Eosinophil granulocytes are activated during the remission phase of ulcerative colitis</article-title>
          <source>Gut</source>
          <year>2005</year>
          <volume>54</volume>
          <issue>12</issue>
          <fpage>1714</fpage>
          <lpage>1720</lpage>
          <issn>0017-5749</issn>
          <publisher-name>BMJ</publisher-name>
        </element-citation>
      </ref>
      <ref id="R224913830271278">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zezos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Patsiaoura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mpoumponaris</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vassiliadis</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Giouleme</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Pitiakoudis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kouklakis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Evgenidis</surname>
              <given-names>N</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy</article-title>
          <source>Colorectal Disease</source>
          <year>2014</year>
          <volume>16</volume>
          <issue>12</issue>
          <fpage>420</fpage>
          <lpage>430</lpage>
          <issn>1462-8910</issn>
          <publisher-name>Wiley</publisher-name>
          <uri>https://doi.org/10.1111/codi.12725</uri>
        </element-citation>
      </ref>
      <ref id="R224913830271266">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christensen</surname>
              <given-names>Britt</given-names>
            </name>
            <name>
              <surname>Hanauer</surname>
              <given-names>Stephen B</given-names>
            </name>
            <name>
              <surname>Erlich</surname>
              <given-names>Jonathan</given-names>
            </name>
            <name>
              <surname>Kassim</surname>
              <given-names>Olufemi</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>Peter R</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>Jerrold R</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>John</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>David T</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes</article-title>
          <source>Clinical Gastroenterology and Hepatology</source>
          <year>2017</year>
          <volume>15</volume>
          <issue>10</issue>
          <fpage>1557</fpage>
          <lpage>1564</lpage>
          <issn>1542-3565</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.cgh.2017.02.016</uri>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
